<DOC>
	<DOCNO>NCT01412853</DOCNO>
	<brief_summary>Context : Prostate cancer common non-cutaneous cancer second common cause cancer-related death European North-American men . After external radiotherapy brachytherapy , Prostate Specific Antigen ( PSA ) value often fluctuate PSA nadir may reach 2 year may remain detectable several year completion radiation . Moreover , PSA bounce blip render patient physicians anxious possibility relapse . In context , biomarkers could predict response radiation earlier PSA patient prostate cancer appear long overdue . Magnetic Resonance Spectroscopy 3 Tesla without endorectal coil non invasive procedure allow quantification metabolite Choline , Creatine , Polyamines Citrate within prostate gland . Objectives : The investigator conduct French prospective study Evaluation Response Irradiation MR Spectroscopy ( ERIS ) . Their purpose monitor early response radiation 3D MR Spectroscopy first year completion radiation impact biochemical control . Therefore , ERIS trial aim investigate whether could correlation time course PSA Choline Citrate .</brief_summary>
	<brief_title>Spectro-IRM Evaluation Response Prostatic Radiotherapy</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>1 . Patients biopsyproven prostatic adenocarcinoma 2 . Gleason score 4 10 3 . Maximal baseline PSA &lt; 50 ng/ml 4 . Age = 18 yr 5 . Exclusive radiotherapy and/or brachytherapy without androgen deprivation therapy 6 . Written informed consent patient 1. lymphnode metastasis 2 . Bone metastases 3 . Maximal baseline PSA ≥ 50 ng/ml 4 . Prior radical prostatectomy 5 . Contraindications MRI ( Pacemaker , hip prothesis… )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>localize</keyword>
</DOC>